Myelin proteolipid protein (PLP), but not DM-20, is an inositol hexakisphosphate-binding protein

被引:28
|
作者
Yamaguchi, Y
Ikenaka, K
Niinobe, M
Yamada, H
Mikoshiba, K
机构
[1] OKAZAKI NATL RES INST,NATL INST PHYSIOL SCI,LAB NEURAL INFORMAT,OKAZAKI,AICHI 444,JAPAN
[2] OSAKA UNIV,INST PROT RES,DIV REGULAT MACROMOL FUNCT,SUITA,OSAKA 565,JAPAN
[3] INST PHYS & CHEM RES,TSUKUBA LIFE SCI CTR,MOL NEUROBIOL LAB,TSUKUBA,IBARAKI 305,JAPAN
[4] UNIV TOKYO,INST MED SCI,DEPT MOL NEUROBIOL,MINATO KU,TOKYO 108,JAPAN
关键词
D O I
10.1074/jbc.271.44.27838
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Myelin proteolipid protein (PLP) and its alternatively spliced isoform, DM-20, are the major integral membrane proteins of central nervous system myelin. It is known that PLP and DM-20 are delivered to myelin by a finely regulated vesicular transport system in oligodendrocytes. Evolutionarily, it is believed that ancestral DM-20 acquired a PLP-specific exon to create PLP, after which PLP/DM-20 became a major component of central nervous system myelin. We purified PLP as an inositol 1,3,4,5-tetrakisphosphate-binding protein after solubilization in a non-organic solvent. However, under the Isotonic condition, PLP binds inositol hexakisphosphate (InsP(6)) significantly, not inositol 1,3,4,5-tetrakisphosphate. Most of the InsP(6)-binding proteins are involved in vesicular transport, suggesting the involvement of PLP in vesicular transport. We separated DM-20 from PLP by CM-52 chromatography and showed that DM-20 has no InsP(6) binding activity. These findings indicate that the PLP-specific domain confers the InsP(6) binding activity and this interaction may be important for directing PLP transport to central nervous system myelin.
引用
收藏
页码:27838 / 27846
页数:9
相关论文
共 50 条
  • [41] Characterization of an intronic enhancer that regulates myelin proteolipid protein (Plp) gene expression in oligodendrocytes
    Meng, FX
    Zolova, O
    Kokorina, NA
    Dobretsova, A
    Wight, PA
    JOURNAL OF NEUROSCIENCE RESEARCH, 2005, 82 (03) : 346 - 356
  • [42] MYELIN PROTEOLIPID PROTEIN (PLP) REACTIVITY IN MULTIPLE-SCLEROSIS AND MATCHED, HEALTHY CONTROLS
    PELFREY, CM
    TROTTER, JL
    TRANQUILL, LR
    MCFARLAND, HF
    FASEB JOURNAL, 1994, 8 (04): : A246 - A246
  • [43] Myelin proteolipid protein (Plp) intron 1 DNA is required to temporally regulate Plp gene expression in the brain
    Wight, PA
    Li, S
    Moore, CL
    Dobretsova, A
    JOURNAL OF NEUROCHEMISTRY, 2002, 81 : 6 - 6
  • [44] ACUTE OPTIC NEURITIS INDUCED BY IMMUNIZATION WITH THE CNS SPECIFIC MYELIN PROTEOLIPID PROTEIN (PLP)
    POTTER, NT
    BIGAZZI, PE
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1991, 32 (04) : 682 - 682
  • [45] Potentiation of myelin proteolipid protein (Plp) gene expression is mediated through AP-1-like binding sites
    Dobretsova, A
    Kokorina, NA
    Wight, PA
    JOURNAL OF NEUROCHEMISTRY, 2004, 90 (06) : 1500 - 1510
  • [46] OVER-EXPRESSION OF THE DM-20 MYELIN PROTEOLIPID CAUSES CENTRAL-NERVOUS-SYSTEM DEMYELINATION IN TRANSGENIC MICE
    JOHNSON, RS
    RODER, JC
    RIORDAN, JR
    JOURNAL OF NEUROCHEMISTRY, 1995, 64 (03) : 967 - 976
  • [47] Characterization of myelin basic protein (MBP) and proteolipid protein (PLP) isoforms in the myelopathy of acquired immunodeficiency syndrome (aids).
    Wolf, DA
    Dholakia, SR
    Olano, J
    Gelman, BB
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1996, 55 (05): : 216 - 216
  • [48] THE EVOLUTION OF MYELIN PROTEOLIPID PROTEIN
    SCHLIESS, F
    STOFFEL, W
    BIOLOGICAL CHEMISTRY HOPPE-SEYLER, 1990, 371 (11): : 1030 - 1030
  • [49] IMMUNOCHEMISTRY OF THE MYELIN PROTEOLIPID PROTEIN
    POTTER, NT
    LEES, MB
    JOURNAL OF NEUROIMMUNOLOGY, 1987, 16 (01) : 141 - 141
  • [50] Evolution of myelin proteolipid protein and myelin basic protein.
    Kurihara, T
    KasamaYoshida, H
    Sakuma, M
    Gojobori, T
    Kojima, H
    Tamai, Y
    JOURNAL OF NEUROCHEMISTRY, 1997, 69 : S126 - S126